{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9HCD5",
      "entity_text" : "CIA",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03397",
      "entity_text" : "LS-101",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Prophylactic administration of either LS-101 or LS-102 also significantly reduced the severity of murine CIA (XREF_FIG).",
  "reading_complete" : "2020-08-03T15:35:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:33:46Z",
  "trigger" : "reduced",
  "evidence" : [ "LS-101 or LS-102 also significantly reduced the\nseverity of murine CIA" ],
  "pmc_id" : "4042867",
  "score" : 0
}